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Introduction
TNF exerts its many different functions in the body through
two different receptors. Since their discovery 15 years ago,
there has been intense investigation of whether both receptors
perform similar functions and act in a cooperative way
or whether they perform separate biological functions
(Vandenabeele et al., 1995a; Wallach et al., 1997). TNF
receptor 1 (TNFR1) is the main signaling receptor both for the
induction of cell death and gene regulation, while the function
of TNFR2 seems mostly restricted to T-cells, where it is
involved in proliferation, gene activation and apoptosis
(Aspalter et al., 2003; Kafrouni et al., 2003; Kim and Teh,
2001; Zheng et al., 1995). The involvement of TNFR2 in TNF-
mediated cell death is controversial; does it somehow modulate
the TNFR1 signal or does it mediate TNF-induced apoptosis
in a direct way? Others and we have argued that TNFR2 is fully
capable of direct involvement in cell death (Haridas et al.,
1998; Pimentel-Muinos and Seed, 1999; Vandenabeele et al.,
1995b; Vandenabeele et al., 1992). This view is supported
by genetic in vivo studies demonstrating that cytotoxic T
lymphocytes from TNFR1 knockout animals still undergo
TNF-dependent apoptosis (Zheng et al., 1995). Alternatively,
different mechanisms by which TNFR2 may make use of
TNFR1 signaling have been proposed. One such mechanism is
that TNFR2 activation induces production of endogenous TNF
that in turn activates TNFR1 (Grell et al., 1999; Vercammen et
al., 1995). To our knowledge, this mechanism has not been
observed in T-cells. A second mechanism by which the two
TNF receptors can cooperate is ligand passing (Tartaglia and
Goeddel, 1992; Tartaglia et al., 1993). It has been proposed that
TNFR2 acts as a high affinity receptor with high Kass and low
Koff values, allowing TNF to pass from the highly abundant
TNFR2 to a less abundant TNFR1. We previously showed that
intracellular mutations of TNFR2 abolished the observed
cytotoxicity in PC60 cells (Declercq et al., 1998) and that
TNFR2-specific muteins of human TNF (Van Ostade et al.,
1994) still induce cell death. This suggests that TNFR2 is a
true signal transducing receptor system.
A recent set of publications concerning TNF-receptor
cooperation in cell death models suggests that TNFR2
modulates the complex signaling machinery engaged by
TNFR1. Many components of the TNFR1-induced signaling
pathway have been identified, and their role in signaling has
been established (reviewed by Chen and Goeddel, 2002).
After ligand binding, the aggregated intracellular part of the
receptor recruits a number of adaptor molecules, TRADD
(TNFR1 associated protein with death domain), TRAF2
(TNFR1 associated factor 2) and RIP1 (receptor interacting
protein), forming the so-called TNF-signaling complex I
(Harper et al., 2003; Micheau and Tschopp, 2003; Shu et al.,
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Previously we reported that both human TNFR1 and
TNFR2 mediate TNF-induced apoptosis in the transfected
rat/mouse T cell hybridoma PC60. We show here that
TNFR2-mediated apoptosis in PVC60 cells can be blocked
by the broad-spectrum caspase inhibitor zVAD-fmk, the
caspase-8 inhibitor zIETD-fmk and by CrmA, a viral
inhibitor of caspase-1 and caspase-8. This suggests an
involvement of caspase-8 in TNFR2-mediated apoptosis.
The upstream adaptor of caspase-8, FADD, is also
involved in TNFR2-induced cell death, since transient
overexpression of a dominant negative deletion mutant of
FADD inhibited apoptosis induced by this receptor.
TNFR2-induced apoptosis is independent of endogenous
TNF or other death-inducing ligand production and
subsequent activation of TNFR1 or other death receptors.
Furthermore, TNFR2 stimulation does not enhance
sensitivity for a subsequent TNFR1-induced apoptotic
signal, as has been reported for Jurkat cells. TRAF2
downregulation, which has been proposed as the
mechanism by which TNFR2 enhances TNFR1 signaling,
was observed in PC60 cells, but the TNRF1 signal was not
modulated. These data confirm the capacity of TNFR2 to
generate an apoptotic cell death signal independent of
TNFR1.
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1996). This adaptor-complex dissociates from the TNFR1
receptor and TRADD recruits FADD (Fas-associated protein
with death domain), caspase-8 and caspase-10, forming the
TNF-signaling complex II (Micheau and Tschopp, 2003). It is
important to mention that a truncated FADD molecule, FADD-
DN (FADD dominant negative), which does not contain the
N-terminal death effector domain (DED), will block the
activation of caspase-8 in this complex (Chinnaiyan et al.,
1995). Through the activation of caspase-8 and -10, TNFR1
initiates the apoptotic process and further activates
downstream caspases, while the complex I molecules TRAF2
and RIP1 are responsible for signaling to gene expression and
notably to anti-apoptotic mechanisms. This mechanism was
described in human cells, but it is very likely that it also
operates in rodent cells, with the sole difference that no mouse
or rat caspase-10 has been identified (Lamkanfi et al., 2002).
It has been proposed that TNFR2 influences TNFR1 signaling
precisely through TRAF2. This model is primarily based on
observations in Jurkat and other cell lines. These cells become
sensitive to TNF after overexpression of TNFR2, but
stimulating this receptor with agonistic antibodies alone does
not kill the cells, or does so only with low efficiency (Chan
and Lenardo, 2000; Fotin-Mleczek et al., 2002; Weiss et al.,
1997). This means that in these cell lines TNFR1 activation
is required for TNFR2-induced cell death. The proposed
mechanism is that TNFR2 recruitment and subsequent
degradation of TRAF2 interferes with the anti-apoptotic
signaling of TNFR1. This model is further supported by the
observation that TNFR2-specific prestimulation some hours
before TNF treatment enhances the sensitivity to the cytotoxic
action of TNF (Chan and Lenardo, 2000; Fotin-Mleczek et al.,
2002). This model, however, does not explain the data
presented by Pimentel-Muiños and Seed who, using Jurkat
cells similarly transfected with TNFR2, could not block TNF-
mediated toxicity using TNFR1-neutralizing antibodies
(Pimentel-Muinos and Seed, 1999). It is unfortunate that no
receptor-specific stimulation of TNFR2 was used on these
cells. These authors also provide genetic evidence that RIP1
is necessary for TNFR2-mediated cell death, and they show
RIP1 and TRAF2 dependent recruitment of the death-inducing
adaptor FADD to the intracellular part of TNFR2 (Pimentel-
Muinos and Seed, 1999).
To study TNFR2-induced apoptosis in T-cells, we made use
of PC60 cells. PC60 cells expressing both human TNF
receptors (PC60 R1R2) exhibit TNF-dependent apoptosis
that can be mediated by either TNFR1 or TNFR2, or by
simultaneous triggering of both TNF receptors (Vandenabeele
et al., 1995b). We have already shown that the TRAF2
recruitment domain of TNFR2 is required for the observed
cytotoxic effect (Declercq et al., 1998). In the present study
we show that TNFR2-mediated cell death is dependent on
FADD and on a caspase that is inhibited by CrmA (cytokine
response modifier A), zIETD-fmk and zVAD-fmk, most
probably caspase-8. It was also observed that TRAF2 was
downregulated by TNFR2, but not by TNFR1. However, death
of PC60 cells induced by TNFR2 is not dependent on a
simultaneous trigger of TNFR1. We also present data showing
that TNFR2-dependent TRAF2 downregulation does not
sensitize the PC60 cells to subsequent TNFR1-mediated
killing. These data support the notion that TNFR2-induced
apoptosis in T-cells operates independently of TNFR1.
Materials and Methods
Cells and cytokines
The hybridoma PC60.21.14.4, provided by M. Nabholz (Swiss
Institute of Experimental Cancer Research, Epalinges, Switzerland),
was transfected with cDNAs coding for TNFR1, TNFR2 or both, as
previously reported (Vandenabeele et al., 1995b). The PC60 R1R2
were previously named ‘PC60 TNF-R55/R75 cl5’. Purified E. coli-
derived human TNF, the human TNFR1-specific mutein R32WS86T
and the human TNFR2-specific mutein D143NA145R were prepared
in our laboratory as described previously (Vandenabeele et al., 1995b).
DNA constructs and electroporation of PC60 cells
The expression plasmids pCAGGSCrmA (encoding Cowpox Crm)
and pCDNAFADD-DN (encoding amino acids 80-205 of the wild
type FADD) have been described previously (Boone et al., 2000;
Vercammen et al., 1997). The pNFconluc construct contains the
luciferase gene under control of the minimal chicken conalbumin
promoter preceded by three NF-κB sites (Kimura et al., 1986).
pUT651, a β-gal expression plasmid, was obtained from Eurogentec
(Seraing, Belgium). For stable transfections, PC60 R1R2/5 cells (107)
were electroporated as reported previously (Declercq et al., 1995). A
combination of the plasmids pCAGGSCrmA (10 µg) and pNFconluc
(10 µg), or pNFconluc alone (10 µg) combined with 1 µg of the
selection plasmid pSV2Neo (G418 selection) was added to the cells
and the mixture was exposed to a single electropulse (1500 µF, 300
V). Two days later, G418 (1500 µg; Life Technologies, Paisley, UK)
was added and the cells were cloned by means of limiting dilution.
For transient expression, pUT651 (10 µg) combined with
pCDNAFADD-DN (20 µg) or the control vector pCDNAI (20 µg)
were electroporated as described. Assays were performed 24 hours
after electroporation.
Immunoblotting
Cell lysates were subjected to SDS-PAGE and immunoblotted using
a CrmA-specific rabbit polyclonal antiserum, rabbit anti-caspase-3
antiserum (Denecker et al., 2001), a monoclonal FADD-specific
antibody (Transduction Laboratories, Lexington KY), or TRAF2
(Santa Cruz Biotechnology). Detection was performed using the ECL
system (Amersham Life Science, Amersham, UK).
Propidium iodide exclusion assay
Cells were seeded in 96-well microtiter plates at 5×104 cells/well or
24-well plates at 105 cells/well. They were treated, for the times
indicated in the figure legends, with saturating concentrations of
hTNF (100 ng/ml) or its receptor-specific muteins R32WS86T
(hTNFR1, 500 ng/ml) or D143NA145R (hTNFR2, 500 ng/ml)
(Loetscher et al., 1993). The number of apoptotic cells in a given
culture was measured by a propidium iodide (PI) exclusion assay as
described previously (Vandenabeele et al., 1995b). PI was added at a
final concentration of 30 µM and cells were analyzed on an Epics 753
fluorometer or a FACS-Calibur flow cytometer (Becton Dickinson,
Sunnyvale, CA). When used, the protease inhibitors zVAD-fmk or
zDEVD-fmk (Enzyme Systems Products, Dublin, CA) or zIETD-fmk,
the granzyme B inhibitor zAAD-fmk or zYVAD-cmk (Calbiochem-
Novabiochem International, San Diego, CA) were added 1 hour prior
to TNF or the TNF muteins.
β-galactosidase cell death assay
Transiently transfected cells were stimulated overnight either with
control medium, 500 ng/ml R32WS86T, 500 ng/ml D143NA145R or
100 ng/ml hTNF. Subsequently, cells were stained with 5-bromo-4-
chloro-3-indolyl-β-D-galactoside (X-gal) as described previously
(Chinnaiyan et al., 1996). β-gal-stained blue cells were examined
Journal of Cell Science 118 (3)
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microscopically for apoptotic features, such as membrane blebbing
and nuclear changes, after which the percentage of induced apoptotic
cells was determined (500 cells were counted in each assay).
Luciferase assay
PC60 transfectants were cultured in the absence or presence of hTNF
and lysed after 6 hours of stimulation according to the luciferase assay
protocol of Promega Biotec (Madison, WI). Luciferin (Duchefa
Biochemie, Haarlem, The Netherlands) was added and luciferase
activity was measured on a Topcount Luminometer (Packard
Instrument Co., Meriden, CT).
Results
TNFR2 induces apoptosis in PC60 cells
As we reported previously (Vandenabeele et al., 1995b), both
human TNF receptors are equally capable of inducing
apoptosis when transfected in the T cell hybridoma PC60
(PC60 R1R2 cells) (Fig. 1). The percentage of propidium
iodide (PI)-positive cells was taken as a measure of apoptotic
death in these cultures. We previously correlated PI
measurements with other parameters of apoptosis, such as
annexin V staining and DNA fragmentation, in PC60 R1R2
cells and excluded other types of cell death, such as necrosis,
after TNF stimulation in these cells (Denecker et al., 2000;
Vandenabeele et al., 1995b). Annexin V staining occurs
earlier (6-9 hours) than PI-positivity in these cells upon TNF
treatment, but eventually the annexin V-positive cells will
become PI positive after 16 to 20 hrs (data not shown). Hence,
PI-positivity is a valid parameter for apoptotic cell death in
PC60 cells. Individual triggering of either TNF receptor is
achieved through stimulation with muteins of hTNF that are
capable of binding only one receptor: R32WS86T triggers
TNFR1 while D143NA145R is specific for TNFR2
(Loetscher et al., 1993). When PC60R1R2 cells were treated
with both muteins together, this resulted in an additive
amount of cell death comparable to what is observed with
hTNF (Fig. 1).
Caspase-8 inhibitors block TNFR2-induced apoptosis
Apoptosis is most often dependent on caspase activity, so it is
hardly surprising that the broad-spectrum caspase inhibitor
zVAD-fmk prevents TNF-mediated cell death in PC60 cells
(Fig. 2A). As a control, the granzyme B inhibitor zAAD-fmk
had no effect in the same assay. As shown in Fig. 2B, zVAD-
fmk is equally capable of inhibiting cell death induced by
TNFR1 or by TNFR2. It is important to point out that the
combination of zVAD-fmk and TNFR2-specific stimulation
did not result in necrotic cell death, not even after extended
observation of the cells (72 hours, data not shown), as has been
reported for Jurkat cells (Chan et al., 2003). In an attempt to
get more information about the identity of caspases involved
in this process, we tested the ability of several caspase
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Fig. 1. Both TNF rceptors induce apoptosis in PC60 R1R2 cells.
PC60 R1R2 cells were treated for 20 hours with 100 ng/ml hTNF or
its receptor-specific muteins (500 ng/ml). The percentage of
apoptotic cells was determined using propidium iodide exclusion.
Fig. 2. Both TNFR1- and TNFR2-mediated apoptosis in PC60 R1R2
cells are blocked by the caspase inhibitor zVAD-fmk. (A) PC60
R1R2luc cells were seeded in microtiter plates and left untreated or
were stimulated with saturating amounts of hTNF (100 ng/ml) in the
presence (100 µM) or absence of the synthetic peptide caspase
inhibitors zVAD-fmk, zDEVD-fmk, zYVAD-cmk, zIETD-fmk or the
granzyme B inhibitor zAAD-fmk. Cells were cultured for 20 hours
before cell death was measured by cytofluorometric analysis of PI
uptake. (B) The experimental procedure was the same as in A. Cells
were incubated with hTNF or its receptor-specific muteins
R32WS86T or D143NA145R (500 ng/ml) in the absence or presence
of zVAD-fmk. (C) Cells were treated for 7 hours in the presence of
100 ng/ml hTNF, in the presence or absence of peptide inhibitors
zDEVD-fmk or zVAD-fmk. Cell lysates were analyzed by means of
western blotting with a caspase-3 antibody. Pro is the unprocessed
procaspase-3, and p20 is the processed form with the black
arrowhead showing the normal p20 subunit and the white arrowhead
showing a shifted band indicative of a covalent bond between the p20
and zDEVD-fmk. (D) The experimental procedure was the same as
in A. Cells were lysed 6 hours after stimulation and luciferase
activity determined.
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inhibitors to interfere with TNF-induced apoptosis in PC60
cells (Fig. 2A). The inhibitors zYVAD-fmk, zDEVD-fmk and
zIETD-fmk have been shown to be specific for caspase-1-like,
caspase-3-like and caspase-8-like activities, respectively.
Although high concentrations of these modified peptides were
used (up to 200 µM in some experiments, data not shown),
neither zYVAD-fmk nor zDEVD-fmk inhibitors were able to
block the TNF-dependent cell killing, excluding a major role
for caspase-1 and caspase-3 in the TNF-induced apoptotic
death of PC60 cells (Fig. 2A). Since DEVD peptide inhibitors
are capable of inhibiting apoptosis in many cell lines but did
not affect TNF-induced apoptosis in PC60R1R2 cells, we
verified whether this inhibitor is capable of entering the PC60
cells. Therefore we measured DEVDase activity in cell lysates
from untreated and TNF-treated cells. The TNF-induced
DEVDase activity was inhibited (90% inhibition) in zDEVD-
fmk-treated cell cultures (data not shown). In addition, we
could show that the p17 fragment, containing the catalytic
cystein of activated caspase-3, shows an upward shift when
cells were treated in the presence of zDEVD-fmk, indicative
of a covalent bond between the enzyme fragment and the
peptide-inhibitor (Fig. 2C). This shift is also seen when lysates
of TNF-treated cells, containing activated caspase-3, were
incubated with zDEVD-fmk in vitro (data not shown).
Caspase-3 processing was not observed when TNF stimulation
occurred in the presence of the broad-spectrum caspase
inhibitor zVAD-fmk. These findings indicate that the peptide
inhibitor zDEVD-fmk was capable of entering the cells and
also that a zVAD-fmk-sensitive protease, most probably an
initiator caspase, is activated upstream of caspase-3. In contrast
to zDEVD-fmk and zYVAD-fmk, the inhibitor zIETD-fmk did
substantially reduce TNF-mediated apoptosis in the PC60
R1R2, which is a first indication that caspase-8 is the
predominant caspase in TNF-receptor signaling in this cell
line. None of the peptide caspase inhibitors used had an effect
on TNF-induced NF-κB activation, indicating that the
inhibitors did not interfere with TNF signaling in general (Fig.
2D). This was analyzed in PC60 R1R2 cells transfected with
a NF-κB-dependent luciferase expression vector. The
somewhat higher luciferase values in cells treated with
protease inhibitors might be due to a slower degradation of
luciferase. In addition to peptide inhibitors, overexpression of
protein inhibitors can be used to identify the protease involved
in signaling. We stably expressed the cowpox caspase inhibitor
CrmA (Los et al., 1995; Tewari and Dixit, 1995) in PC60 R1R2
cells and confirmed its expression by western blotting (Fig.
3A). CrmA inhibited induction of apoptosis by TNF and by its
receptor specific muteins, which meant that signaling towards
apoptosis through both receptor types was blocked (Fig. 3B).
We also compared the NF-κB activation by TNF in a control
cell line and in the CrmA transfected cells, and found that
CrmA did not inhibit the NF-κB-dependent luciferase activity
stimulated by TNF (data not shown). Our data point to the
crucial involvement of one or more caspases in TNFR2-
mediated cell death that can be inhibited by zVAD-fmk,
zIETD-fmk and CrmA but not by zYVAD-cmk and zDEVD-
fmk. The obvious candidate is caspase-8, whose activity is,
like caspase-1, blocked by CrmA but not by the caspase-1
inhibitor zYVAD-cmk (Garcia-Calvo et al., 1998; Muzio et al.,
1996).
FADD-DN blocks TNFR2-induced apoptosis
Since we found indications of caspase-8 involvement in
TNFR2-mediated apoptosis, we evaluated the potential
involvement of the caspase-8 upstream adaptor FADD in this
pathway. Overexpression of the dominant-negative N-terminal
deletion mutant of FADD (residues 80-205, FADD-DN),
lacking the death effector domain (DED), blocks cell death
induced by death receptors that make use of this adaptor
(Chinnaiyan et al., 1996). Transient overexpression of the
FADD-DN molecule strongly inhibited TNF-induced
apoptosis in PC60 R1R2 cells (Fig. 4A,B). When the
contribution of each receptor was examined using the TNF-
receptor specific muteins R32WS86T and D143NA145R, we
found that expression of FADD-DN completely blocks not
only TNFR1-induced cytotoxicity, but also that induced by
TNFR2 (Fig. 4B). This finding suggests that direct TNFR2
signaling to the FADD/caspase-8 apoptosis mechanism is
possible.
Journal of Cell Science 118 (3)
Fig. 3. TNFR1- and TNFR2-mediated apoptosis in PC60 R1R2 cells
are both inhibited by the cowpox caspase inhibitor CrmA. (A) PC60
R1R2 cells were transfected with a combination of the plasmids
pCAGGSCrmA and pNFconluc. After selection and subcloning, cell
lines were isolated that expressed the CrmA protein and produced
elevated levels of luciferase activity after TNF stimulation (named
PC60 R1R2 CrmALuc). Control cells were obtained by only
transfecting pNFconluc and subsequent screening for luciferase
inducibility (PC60 R1R2 luc). Untreated cells were lysed and 100 µg
of protein was subjected to CrmA immunoblot. The arrowhead
shows the position of the CrmA protein. (B) PC60 R1R2luc and
PC60 R1R2CrmAluc cells were cultured in the absence or presence
of hTNF (100 ng/ml) or receptor specific muteins (500 ng/ml) for 20
hours and the percentage of propidium iodide-positive cells was
determined.
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TNFR2-mediated cell death does not occur through
secretion of endogenous TNF or other death-inducing
ligands
In a previous study we reported that addition of a neutralizing,
polyclonal anti-TNF antiserum did not inhibit TNFR2-induced
cell death in PC60 R1R2 cells (Decoster et al., 1998);
Vandenabeele et al., 1994). Since FADD and caspase-8 are
generally associated with TNFR1 or TRAIL signaling (Muzio
et al., 1996; Boldin et al., 1996; Sprick et al., 2000), we
performed additional experiments to evaluate a potential
involvement of TNFR1 or other death-inducing ligands in
TNFR2-induced apoptosis in PC60 R1R2. One mechanism by
which TNFR2 could make use of TNFR1 signaling is through
the secretion of endogenous TNF. Therefore, we stimulated
PC60 R1R2 cells with TNF-receptor-specific muteins in the
presence or absence of htr-5, a TNFR1 specific antagonistic
antibody. As shown in Fig. 5A, TNFR2-induced apoptosis is
unaffected by htr-5, whereas TNFR1-mediated cell death can
be inhibited. We used another approach to confirm the absence
of a role for endogenously produced TNF or other death-
inducing ligands in TNFR2-mediated apoptosis, by repeating
the cytotoxic assay in the presence of the protein synthesis
inhibitor cycloheximide. We found that apoptosis induced by
TNFR1 or TNFR2 is not inhibited by cycloheximide but
actually enhanced (Fig. 5B). Together, these data exclude a role
for endogenous TNF in TNFR2-mediated cell death.
TNFR2 stimulation does not sensitize PC60 cells to
TNFR1-mediated killing
It is clear from our experiments that killing by TNFR2 in PC60
cells occurs independently of TNFR1 ligand stimulation (Fig.
5) (Vandenabeele et al., 1994; Vandenabeele et al., 1995b). In
Jurkat and other cell lines, where TNFR2 modulation of the
TNFR1 pathway is suggested, TNFR2 prestimulation enhances
the sensitivity of these cells for a subsequent TNFR1 trigger.
To investigate whether this is a general phenomenon also
occurring in PC60 cells, PC60 R1R2 cells were pretreated with
the TNF mutein D143NA145R that is specific for TNFR2, and
subsequently exposed to hTNF. Pretreatment with the TNFR2-
specific TNF mutein does not make these cells sensitive to
TNF-induced apoptosis (Fig. 6A). The percentage of cell death
Fig. 4. Both TNFR1- and TNFR2-mediated apoptosis in PC60 R1R2
cells is FADD dependent. (A) PC60 R1R2 were electroporated with:
pUT651, a β-gal expression plasmid, plus pCDNAI (control) or plus
pCDNAFADD-DN, encoding dominant negative FADD (80-205). 48
hours after transfection cells were lysed and 150 µg of protein was
submitted to immunoblotting using a monoclonal FADD-specific
antibody. (B) 24 hours after electroporation, cells were stimulated
overnight either with 500 ng/ml R32WS86T, 500 ng/ml
D143NA145R or 100 ng/ml hTNF. Subsequently, cells were stained
with X-gal and β-gal-positive blue cells were examined
microscopically for apoptotic features, such as membrane blebbing
and nuclear changes, after which the percentage of induced apoptotic
cells was determined (500 blue cells were counted in each
measurement).
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Fig. 5. TNFR2-mediated apoptosis is not dependent on endogenous
production of TNF or other death-inducing ligands. PC60 R1R2 cells
were treated with hTNF or its muteins as in Fig. 1 and the resulting
amount of cell death determined. (A) Incubation in the absence or
presence of 5 µg/ml hTNFR1 antagonizing monoclonal antibody htr-
5. (B) Incubation in the absence or presence of 10 µg/ml
cycloheximide (CHX).
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observed with TNFR1-specific stimulation after TNFR2
prestimulation is higher than with TNFR1 stimulation alone,
but this is just an additive effect and not a real sensitization.
An enhanced sensitivity to hTNF in D143NA145R-
prestimulated PC60 R1R2 cells might alternatively be masked
by an upper limit in the amount of apoptosis that can be
induced in these cells. To examine this possibility, TNFR2
prestimulated cells were treated with different concentrations
of hTNF (Fig. 6B). TNFR2 prestimulation did not enhance
sensitivity for hTNF, since the amount of hTNF needed in both
prestimulated and non-prestimulated cells for half maximal
killing lies in the 10-20 ng/ml range for both conditions.
In Jurkat cells, TNFR2-mediated sensitization of TNFR1-
dependent cytotoxicity is attributed to downregulation of
TRAF2 (Fotin-Mleczek et al., 2002). We observe that PC60
R1R2 cells show strongly decreased levels of TRAF2
expression upon TNFR2 stimulation (Fig. 6C). As this cell line
does not exhibit an enhanced cytotoxic response after TNFR2
prestimulation (Fig. 6), we conclude that downregulation of
TRAF2 by TNFR2 is not sufficient to enhance TNFR1-
mediated cell death in PC60 R1R2 cells.
Discussion
Our results indicate that in the rat-mouse cytotoxic T-cell
hybridoma PC60 transfected with human TNF rceptors, TNFR2
is fully capable of inducing cell death independently of TNFR1
ligand stimulation. Simultaneous triggering of both TNF
receptor types has an additive effect (Vandenabeele et al.,
1995b). In most cell types, TNFR1 is the main TNF rceptor that
signals towards cell death, while TNFR2-mediated apoptosis in
vivo is observed only in T-cells. When different subsets of T-
cells were investigated, TNFR2 was found to regulate apoptosis
only in CD8+ CTL (cytotoxic T lymphocytes) (Kim and Teh,
2001; Zheng et al., 1995). Much of the confusion about the role
of TNFR2 in TNF-induced apoptosis could be attributed to
differences in the types of cells used. In many non-lymphoid
cells, TNFR2-induced signaling is attributed to the stimulation
of TNFR1, ligand passing from TNFR2 to TNFR1 (Tartaglia et
al., 1993), or the induced secretion of endogenous TNF (Grell
et al., 1999; Vercammen et al., 1995). We have already ruled
out the involvement of endogenous TNF or ligand passing in
TNFR2-mediated effects on PC60 cells before (Declercq et al.,
1998; Declercq et al., 1995; Vandenabeele et al., 1995b;
Vandenabeele et al., 1994) and now we provide conclusive
evidence that the observed TNFR2-mediated cytotoxicity is not
the consequence of other endogenously produced toxic ligands
such as lymphotoxin or TRAIL. Indeed, antagonistic TNFR1
antibodies could not inhibit cell death induced by TNFR2. In
addition, TNFR2 killing could not be blocked by the translation
inhibitor cycloheximide, which rules out the involvement of any
endogenous cytotoxic factor that could be produced upon
TNFR2 stimulation.
Two research groups, using TNFR2-transfected Jurkat cells,
describe TNFR2 as an enhancer of TNFR1-induced cell death
incapable of independently inducing apoptosis (Chan and
Lenardo, 2000; Fotin-Mleczek et al., 2002). The enhancement
mechanism had already been observed in non-lymphoid cells
(Fotin-Mleczek et al., 2002; Weiss et al., 1997). It is proposed
that TNFR2 disrupts anti-apoptotic signals generated by
TNFR1 while the cell death signals remain. This mechanism
could correlate with the observed TRAF2 degradation in Jurkat
cells (Fotin-Mleczek et al., 2002). This degradation follows
TRAF2 recruitment to TNFR2 and is dependent on
ubiquitination and cIAP-1 (Li et al., 2002). TNFR2 stimulation
is also reported to enhance Fas-mediated cell death (Elzey et
al., 2001). Since Fas does not employ TRAF2 for signaling,
the TRAF2 downregulation mechanism does not seem to be
universal. In contrast to the Jurkat cell model, we observed cell
death in PC60 R1R2 cells after clustering of TNFR2 alone.
TRAF2 expression levels also diminished drastically upon
TNFR2 triggering of PC60 cells, but this did not result in
increased sensitivity to TNFR1-mediated death as was
observed in Jurkat cells. This experiment suggests that in PC60
cells TNFR2-mediated cell death may occur through a
mechanism distinct from that in Jurkat cells. This difference
Journal of Cell Science 118 (3)
Fig. 6. TNFR2 stimulation does not sensitize PC60 R1R2 cells for a
subsequent TNFR1-mediated apoptotic signal. (A) PC60 R1R2 cells,
preincubated for 14 hours in medium or medium containing 500
ng/ml of the TNFR2-specific mutein D143NA145R were stimulated
with 100 ng/ml hTNF, the TNFR1 specific mutein R32WS86T (500
ng/ml) or a combination of both receptor specific muteins. (B) Cells
preincubated as in A were exposed to a dilution range of hTNF as
indicated. (C) Western blot, revealed with anti-TRAF2, of lysates of
PC60 R1R2 cells that were treated for 14 hours with hTNF (100
ng/ml) or its receptor specific muteins (500 ng/ml).
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could be attributed to the CD8+ CTL origin of PC60 cells
(Conzelmann et al., 1982) compared to Jurkat cells, which are
CD4+ (Lifson et al., 1986) and show TNFR2 functionality
reminiscent of non-lymphoid cells (Fotin-Mleczek et al., 2002;
Weiss et al., 1997). It has been shown that TNFR2 has distinct
functions in CD8+ cells. In these cells TNFR2 can act as a
costimulatory molecule for T cell receptor stimulation,
(Aspalter et al., 2003; Kim and Teh, 2001) and is necessary for
the efficient clearance of adenovirus-infected hepatocytes
(Kafrouni et al., 2003). More importantly, genetic studies have
shown that TNFR2 is required for apoptosis of CD8+ cells
during activation-induced cell death, whereas TNFR1 is not
(Alexander-Miller et al., 1998; Kim and Teh, 2001; Zheng et
al., 1995). Moreover, TNFR2 is a necessary mediator of HIV-
mediated apoptosis of CD8+ cells (Herbein et al., 1998).
Because TNFR2-mediated killing is dependent on TNFR1
stimulation in many cell systems, our PC60 R1R2 cells are
valuable for the analysis of TNFR2 signaling. Our results
show that TNFR2, like TNFR1, uses the intracellular signal
transduction molecule FADD to activate its death-inducing
pathway. In agreement with FADD involvement in TNFR2
signaling, both TNF receptors can activate the caspase cascade,
which was inhibitable by CrmA and the zIETD-fmk and
zVAD-fmk peptide inhibitors. A major involvement of
caspase-1 or the execution caspases-3 and -7 was excluded
because neither zYVAD-cmk nor zDEVD-fmk inhibited TNF-
mediated apoptosis. It has been reported previously that DEVD
inhibitors do not block TNF-induced apoptosis in different cell
lines (Gamen et al., 1996; Tafani et al., 2000). This observation
may be cell-line-specific since in several other cell lines DEVD
inhibitors prevent TNF-mediated apoptosis (Higuchi et al.,
1997; Wissing et al., 1997).
Most probably, the caspase that is inhibited by CrmA,
zVAD-fmk and zIETD-fmk in these pathways is caspase-8
(Zhou et al., 1997). In both Fas/Apo1- and TNFR1-induced
apoptosis, the N-terminal DED of caspase-8 interacts with the
homologous N-terminal DED of FADD, resulting in the
activation of caspase-8 (Boldin et al., 1996; Muzio et al., 1996).
We think that two alternative hypotheses may be formulated to
explain the mechanism of involvement of FADD and caspase-
8 in TNFR2-mediated apoptosis. Because TNFR2 does not
contain a death domain and direct FADD-TNFR2 interaction
is not reported and seems unlikely, other adaptor molecules
would be needed to recruit FADD to the receptor. Indeed,
Pimentel-Muinos and Seed showed FADD recruitment via
RIP1 and TRAF2 to the TNFR2 signaling complex (Pimentel-
Muinos and Seed, 1999). In addition, we also demonstrated
that FADD, caspase-8 and RIP1 can be recruited to the same
complex (Vanden Berghe et al., 2004). Since these data are
based on overexpression studies, an alternative mechanism
may exist. Recent publications have shown that FADD and
caspase-8 are not recruited into the primary TNFR1 signaling
complex, but only associate with TRADD in a secondary
complex that does not contain the receptor (Harper et al., 2003;
Micheau and Tschopp, 2003). It seems possible that TNFR2
induces a similar secondary signaling complex responsible for
the induction of apoptosis in PC60 cells. Despite the fact that
genetic and biochemical evidence indicates that TNFR2 can
signal to cell death independently of TNFR1, the signaling
complexes involved in TNFR2-induced apoptosis remain
elusive and need further investigation.
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